The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksUpdated•Originally published 14 April 2026•Updated 16 April 2026•

1 min read

Major Banks Cut Price Targets for BlackRock, Prudential, and Bristol Myers Squibb

Key Facts

1UBS Group lowered BlackRock (BLK) price target to $1,235 while maintaining a 'buy' rating.

2Bank of America reduced Bristol Myers Squibb (BMY) price target to $67.00.

3UBS Group reduced Prudential Financial (PRU) price target to $98.00 with a 'neutral' rating.

about 2 months ago

Version History

Version 1about 2 months ago

What changed: The story was updated to include a new institutional position by Patten Group, insider selling by an EVP, and the company's announcement regarding dividends and FY2026 EPS guidance.

Major financial institutions have issued downward price target revisions for BlackRock, Prudential, and Bristol Myers Squibb (BMY), with Bank of America cutting BMY's target to $67.00. Amidst these revisions, Patten Group Inc. initiated a new position in Bristol Myers Squibb valued at $1.04 million, acquiring 19,288 shares. Conversely, insider activity was noted as EVP David V. Elkins sold 30,000 shares of the company. Bristol Myers Squibb also announced its latest quarterly dividend and provided forward-looking EPS guidance for fiscal year 2026. These developments highlight a complex landscape of institutional entry and insider selling against a backdrop of long-term financial planning.